Predictions
Addus Homecare Corp.
Start price
Target price
Perf. (%)
€100.00
28.02.23
28.02.23
-
28.02.24
28.02.24
-16.50%
29.02.24
29.02.24
T2 Biosystems Inc.
Start price
Target price
Perf. (%)
€0.28
08.08.23
08.08.23
€1.00
08.02.24
08.02.24
-41.28%
08.02.24
08.02.24
Lantheus Holdings Inc
Start price
Target price
Perf. (%)
€57.50
06.02.23
06.02.23
-
06.02.24
06.02.24
-11.13%
07.02.24
07.02.24
ShockWave Medical Inc
Start price
Target price
Perf. (%)
€175.45
06.02.23
06.02.23
-
06.02.24
06.02.24
26.36%
07.02.24
07.02.24
Vivani Medical Inc.
Start price
Target price
Perf. (%)
€0.97
25.12.23
25.12.23
€12.00
25.12.24
25.12.24
-6.22%
04.02.24
04.02.24
Accelerate Diagnostics Inc.
Start price
Target price
Perf. (%)
€1.01
19.01.24
19.01.24
-
19.01.25
19.01.25
10.89%
20.01.24
20.01.24
Cytosorbents Corp.
Start price
Target price
Perf. (%)
€1.83
17.09.23
17.09.23
-
17.09.24
17.09.24
-52.14%
19.01.24
19.01.24
Probably not worthwhile Investment
Bovie Medical Corp
Start price
Target price
Perf. (%)
€2.34
16.10.23
16.10.23
-
16.10.24
16.10.24
-15.38%
11.12.23
11.12.23
Risky Investment
Community Health Systems Inc.
Start price
Target price
Perf. (%)
€2.00
30.10.23
30.10.23
-
30.10.24
30.10.24
15.00%
11.12.23
11.12.23
Probably not worthwhile Investment
scPharmaceuticals
Start price
Target price
Perf. (%)
€4.66
13.11.23
13.11.23
-
13.11.24
13.11.24
12.66%
11.12.23
11.12.23
Probably not worthwhile Investment
MicroVision Inc
Start price
Target price
Perf. (%)
€2.44
02.12.23
02.12.23
€2.00
02.12.24
02.12.24
-1.29%
05.12.23
05.12.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
MicroVision Inc
Start price
Target price
Perf. (%)
€2.36
29.11.23
29.11.23
€2.00
29.11.24
29.11.24
3.49%
02.12.23
02.12.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
MicroVision Inc
Start price
Target price
Perf. (%)
€2.23
23.11.23
23.11.23
€2.00
23.11.24
23.11.24
5.92%
29.11.23
29.11.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
MicroVision Inc
Start price
Target price
Perf. (%)
€2.11
27.09.23
27.09.23
€4.00
27.09.24
27.09.24
5.76%
23.11.23
23.11.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected